Biobanking Teeth Could Help To Forecast Mental Health Problems

Teeth could serve as an actionable new tool capable of measuring the presence and timing of childhood adversity, a major risk factor for psychiatric and physical health concerns in the future. The novel approach is outlined in...
Traumatic brain injury can increase the risk of neurodegenerative diseases.

Biobanking Science: Biomarkers for Traumatic Brain Injury

Traumatic brain injury has been in the news lately because even mild traumatic brain injury, or concussion, can increase the risk of developing neurodegenerative diseases like Parkinson’s disease (1). Many parents have understandably been worried about their children suffering...
CSF Biomarkers may help diagnose patients with neurological diseases

Biobanking Science: CSF Biomarkers for Neurological Diseases

Biobanks can help in the search for biomarkers to diagnose brain diseases. Neurological diseases can be difficult to diagnose as they may have overlapping symptoms. Furthermore, there are currently no diagnostic tests for diseases such as Amylotrophic lateral sclerosis...

Biomarker Candidates For Dementia With Lewy Bodies Identified In Cerebrospinal Fluid

Besides Alzheimer’s disease (AD), Dementia with Lewy Bodies (DLB) is the second most common form of progressive dementia, accounting for up to 20% of cases. The main protein component of Lewy Bodies, which form in the nerve...

A New Blood Test Algorithm mPoA – Quantifying Biological Aging

People age at different rates determined by both their environment/ lifestyle and genetics. Biological aging is the gradual and progressive decline in body integrity that occurs over time eventually leading to loss of vitality or illness/ disability in some cases....

NanoString Grants Exclusive Global License To Veracyte For Diagnostic Use Of The nCounter® Platform

Veracyte has executed a definitive agreement with NanoString for the exclusive global license to the nCounter® platform for diagnostic use. The strategic transaction positions Veracyte to expand its genomic diagnostics business globally, with the ability to deliver its advanced genomic...

ALS Biomarker Study At Massachusetts General Sponsored By Mitsubishi Tanabe Pharma America

Mitsubishi Tanabe Pharma America, Inc. (MTPA) has announced a collaboration with the Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI) to conduct a study designed to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis (ALS).

Perspective On Cancer Biomarker Biobanks

Liquid biopsy is an area of immense opportunity for the early detection and screening of cancer. Suitable fluids include stool, blood, sputum, urine, and others. This is aided by emerging technology which can allow the measurement of...

CLOVER Study Of PDL1 In NSCLC Demonstrates PCR RNA Expression Analysis Not Equivalent To...

Programmed cell death ligand 1 (PDL1) is approved therapeutic target in lung cancer patients. PDL1 expression above a set threshold must be confirmed by companion immunohistochemistry (IHC) test in order for the patient to be eligible for...

New Acoustofluidic Saliva Exosome Liquid Biopsy For Human Papilloma Virus 16

Unfortunately, cancers that occur in the back of the mouth and upper throat are often not diagnosed until they become advanced, partly because their location makes them difficult to see during routine clinical exams. A report in...

🔥 Most Popular



Featured Vendors
X